NSCLC Mixed Response to Nivolumab: Extra Cranial Response and Progressive Brain Disease

Event ESMO Preceptorship on Immuno Oncology Amsterdam September-October 2016
Session Session 6 Audience Cases
Topics Cytotoxic agents
Non-small-cell lung cancer
Therapy
Biological therapy
Presenter L. Del Carpio Huerta, ES